Trials / Completed
CompletedNCT01270282
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 82 (actual)
- Sponsor
- Auris Medical, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the therapeutic benefit and safety of intratympanic AM-101 injections in comparison to placebo in the treatment of persistent acute inner ear tinnitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AM-101 0.81 mg/mL | |
| DRUG | Placebo |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2011-01-05
- Last updated
- 2015-01-26
Locations
16 sites across 4 countries: United States, Belgium, Germany, Poland
Source: ClinicalTrials.gov record NCT01270282. Inclusion in this directory is not an endorsement.